Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion
NCT02465216
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Tuberculosis
Interventions
OTHER:
Placebo
BIOLOGICAL:
ID93 + GLA-SE
Sponsor
Access to Advanced Health Institute (AAHI)
Collaborators
[object Object]
[object Object]